Trial Profile
Post-Marketing Surveillance of Halaven Injection in Korean Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Mar 2020
Price :
$35
*
At a glance
- Drugs Eribulin (Primary)
- Indications Advanced breast cancer; Male breast cancer
- Focus Adverse reactions
- Sponsors Eisai Korea
- 18 Dec 2018 Status changed from active, no longer recruiting to completed.
- 19 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 15 May 2015 New trial record